Uptiv Health, a Nashville, TN-based infusion care startup, raised $7.5m in seed funding.
Uptiv was built at Redesign Health by Torben Nielsen and the founding team.
The company will use the funding to expand its services and into additional markets in the near future.
Led by Torben Nielsen, CEO and Co-Founder, Uptiv Health is redefining infusion therapy for patients suffering from chronic conditions such as Multiple Sclerosis, Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis and others.
The company is offering appointments after working hours and scheduling for patients, 24/7 access to health care staff via the app, and additional services to reduce cost of care, improve patient experience and support patients’ overall wellbeing.
Uptiv Health is composed of an integrated team of experts and clinicians, including FNPs, RNs, nutritionists and behavioral health specialists. The company offers private infusion suites, wifi, flat-screen TVs w/ access to streaming services, weekend availability and transparent upfront pricing.
The app provides patients accessible virtual care: from onboarding and eliminating all paperwork to appointment scheduling to digital payments. Patients can also use the app to stay in touch with their care team and for symptom-tracking. For providers, the app yields data capture, ongoing disease scoring and assessment and other chronic care management services.
Uptiv Health will accept Medicare, is in-network with many insurance providers including Michigan Blue Cross Blue Shield, Priority Health, Aetna, Humana, United Healthcare and expects to announce more in-network health insurance coverage throughout the year. The company is supported by a centralized, integrated platform powering referrals, workflow aggregation, EMR integration and data analytics to create a seamless care journey for patients and our partners.
Uptiv also announced the launch of a flagship infusion care center in Westland, Michigan, which is open for referrals. The center will hold its Grand Opening Event on August 30.
FinSMEs
03/08/2023